Vecuronium Bromide: Package Insert and Label Information (Page 3 of 3)

Compatibility

Vecuronium bromide is compatible in solution with:
0.9% Sodium Chloride Injection
5% Dextrose Injection
Sterile water for injection
Dextrose 5% and Sodium Chloride Injection
Lactated Ringer’s Injection

Use within 24 hours of mixing with the above solutions.

AFTER RECONSTITUTION

  • When reconstituted with Bacteriostatic Water for Injection: CONTAINS BENZYL ALCOHOL, WHICH IS NOT INTENDED FOR USE IN NEWBORNS. Use within 5 days. May be stored at room temperature or refrigerated.

  • When reconstituted with sterile water for injection or other compatible I.V. solutions: Refrigerate vial. Use within 24 hours. Single use only. Discard unused portion.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

HOW SUPPLIED

Vecuronium Bromide for Injection is supplied as follows:

NDC Number Packaging Configuration Vial Size
10019-481-01 Vecuronium Bromide for Injection 10mL
(diluent not supplied)
Shelf pack carton of 10 individual vials.

Storage

Store dry powder at controlled room temperature 15°-30°C (59°-86°F).

PROTECT FROM LIGHT.

Product Nos.: 1053-10

Mfd. for Baxter Healthcare Corporation
Deerfield, IL 60015 USA
by: Steris Laboratories, Inc.
Phoenix, AZ 85043 USA

6953105310019A1

VECURONIUM BROMIDE
vecuronium bromide injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:10019-481
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Vecuronium Bromide (Vecuronium cation) Vecuronium cation 10 mg
Inactive Ingredients
Ingredient Name Strength
Citric Acid Anhydrous 20.75 mg in 1
Sodium Phosphate Dibasic Anhydrous 16.25 mg in 1
Mannitol 97 mg in 1
Sodium Hydroxide
Phosphoric Acid
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:10019-481-01 10 VIAL (10 VIAL) in 1 CARTON contains a VIAL (10019-481-10)
1 NDC:10019-481-10 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL This package is contained within the CARTON (10019-481-01)
Labeler — Watson Laboratories, Inc.

Revised: 06/2007 Watson Laboratories, Inc.

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.